In addition to SPD, metabolic tumor volume, LDH, and CD19 expression, measurements of tumor immune contexture using parameters like Immunoscore, IS21, B-cell signatures, and stromal and immunosuppressive gene signatures are emerging as important determinants of durable responses to axi-cel intervention (25). Here, CD19 is linked to neoplasm.